Key Takeaways: Centanafadine, a first-in-class NDSRI, shows promise for ADHD treatment across varied age groups, with significant symptom improvement in phase 3 trials. The drug demonstrated a favorable safety profile, with common adverse events being decreased appetite, nausea, and headache, and low abuse potential. Recent studies indicate centanafadine’s potential in addressing emotional dysregulation and executive…

Research shows that eating nutritious meals helps the brain function optimally, but numerous social media posts are claiming that avoiding gluten, dairy, corn and soy can eradicate symptoms of attention deficit hyperactivity disorder (ADHD). Experts said these claims are not backed by robust research, cautioning against strict elimination diets for children.

The quest to understand and treat a pervasive and mystifying mental health condition.

Weddings can be challenging for those with neurodivergence. As awareness grows, vendors are creating sensory-friendly solutions.

UK had highest relative increase of five countries in study, with 20-fold rise in proportion of women over 25 using it

[Excerpt] Along with psychologist and researcher Audhild Løhre, Uthus conducted an interview study focusing on two school children: “Sofie” and “Benjamin.” Both students have ADHD. The researchers followed the pupils and their teachers over the course of one school year during which their school introduced a new model for adapted education. Both pupils describe how…

From APSARD 2026, a patient journey demonstrates opportunities in psychiatric education on stuttering and emerging treatment approaches.

Tim Wilens, MD, discussed mechanism of action and efficacy of new medications at APSARD Conference.

Clinicians explore the complex relationship between ADHD medication and pregnancy, emphasizing individualized risk assessments for optimal maternal and child health.

Adults who receive an ADHD diagnosis later in life may represent a somewhat less severe clinical subtype than those diagnosed in youth, but still experience impairment that warrants clinical attention, according to new data presented at American Professional Society of ADHD and Related Disorders (APSARD) 2026 Annual Conference.1,2

Key point: Compared with standard aerobic exercise, cognitively engaging exercise programs improved sustained attention of children and adolescents with ADHD, with multiple longer sessions having a more significant effect.

A large multicentre clinical trial led by King’s College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.